Global Patent Index - EP 1435926 A4

EP 1435926 A4 20051123 - METHOD FOR TREATMENT AND PREVENTION OF DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM ASSOCIATED WITH AN ALTERATION OF GLUTAMATERGIC NEUROTRANSMISSION BY ADMINISTRATION OF 2-AMINOBENZENESULFONAMIDE DERIVATIVES

Title (en)

METHOD FOR TREATMENT AND PREVENTION OF DISTURBANCES OF THE CENTRAL NERVOUS SYSTEM ASSOCIATED WITH AN ALTERATION OF GLUTAMATERGIC NEUROTRANSMISSION BY ADMINISTRATION OF 2-AMINOBENZENESULFONAMIDE DERIVATIVES

Title (de)

VERFAHREN ZUR BEHANDLUNG UND PRÄVENTION VON STÖRUNGEN DES ZENTRALEN NERVENSYSTEMS IM ZUSAMMENHANG MIT EINER VERÄNDERUNG DER GLUTAMATERGEN NEUROTRANSMISSION DURCH VERABREICHUNG VON 2-AMINOBENZOLSULFONAMID-DERIVATEN

Title (fr)

METHODE DE TRAITEMENT ET DE PREVENTION DE TROUBLES DU SYSTEME NERVEUX CENTRAL ASSOCIES A UNE ALTERATION DE LA NEUROTRANSMISSION GLUTAMATERGIQUE PAR ADMINISTRATION DE DERIVES DE 2-AMINOBENZENESULFONAMIDE

Publication

EP 1435926 A4 20051123 (EN)

Application

EP 02769353 A 20020507

Priority

  • IT BO20010271 A 20010508
  • US 0214262 W 20020507

Abstract (en)

[origin: WO02089734A2] 2-aminobenzenesulfonamide derivatives are used for the treatment or prevention of the disturbances of the central nervous system associated with a positive or negative modulation of glutamatergic neurotransmission, such as disturbances of memory and learning, schizophrenia, sexual disturbances, ischemic attacks, ictus, etc. For example, a compound according to formula (I): is administered to treat or prevent diseases of the central nervous system having a positive or negative modulation of AMPA/Kainate receptors and a negative modulation of NMDA receptors.

IPC 1-7

A61K 31/04

IPC 8 full level

A61K 31/136 (2006.01); A61K 31/18 (2006.01)

CPC (source: EP)

A61K 31/136 (2013.01); A61K 31/18 (2013.01)

Citation (search report)

  • [X] WO 0012073 A1 20000309 - SMITHKLINE BEECHAM PLC [GB], et al
  • [X] EP 0815861 A1 19980107 - HOFFMANN LA ROCHE [CH]
  • [A] D.J.HEALY ET ALL.: "Iontropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain", NEUROPSYCHOPHARMACOLOGY, vol. 21, no. 3, 1999, pages 341 - 351, XP002347588
  • See references of WO 02089734A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 02089734 A2 20021114; WO 02089734 A3 20030306; AU 2002308614 A1 20021118; EP 1435926 A2 20040714; EP 1435926 A4 20051123; IT BO20010271 A0 20010508; IT BO20010271 A1 20021108

DOCDB simple family (application)

US 0214262 W 20020507; AU 2002308614 A 20020507; EP 02769353 A 20020507; IT BO20010271 A 20010508